Myriad Genetics Inc.
320 Wakara Way
Salt Lake City,
UT 84108
United States - Map
Phone: 801-584-3600
Fax: 801-584-3640
Web Site: http://www.myriad.com
| Myriad Genetics, Inc., a healthcare company, focuses on the development and marketing of novel molecular diagnostic products. It commercializes predictive medicine, personalized medicine, and prognostic medicine products. The company markets BRACAnalys for assessing a womans risk for breast and ovarian cancer; COLARIS molecular for assessing a persons risk of developing colorectal cancer or uterine cancer; COLARIS AP, a molecular diagnostic product for colon cancer that detects mutations in the APC and MYH genes; and MELARIS, which assesses a persons risk of developing melanoma. It also offers OnDose, a personalized medicine product to measure a patient's exposure to 5-FU chemotherapy; PREZEON that assesses loss of PTEN function in cancer patients; and TheraGuide 5-FU assesses a person's risk of developing a toxic reaction to 5-FU-based chemotherapy. The company was founded in 1991 and is headquartered in Salt Lake City, Utah. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Peter D. Meldrum Ph.D., 63
Chief Exec. Officer, Pres |
$
1.80M |
$
2.64M | Dr. Walter Gilbert Ph.D., 76
Founding Scientist, Vice Chairman and Member of Compensation Committee |
$
66.00K | N/A | Mr. James S. Evans , 47
Chief Financial Officer, Principal Accounting Officer and Treasurer |
$
641.00K |
$
1.29M | Dr. Gregory C. Critchfield M.D., M.S., 57
Pres of Myriad Genetic Laboratories Inc |
$
967.00K |
$
5.26M | Mr. Richard M. Marsh Esq., 52
Exec. VP, Sec. and Gen. Counsel |
$
571.00K |
$
2.22M |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.11% Nasdaq 
0.01%
Profile
